Time of administration important? Morning versus evening dosing of valsartan

Por Zappe, Dion H., Crikelair, Nora, Kandra, Albert, Palatini, Paolo
Publicado no J Hypertens (2015)

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

Por Anand, Inder S, Deswal, Anita, Kereiakes, Dean J, Purkayastha, Das, Zappe, Dion H
Publicado em 2010

Antihypertensive and Metabolic Effects of Angiotensin Receptor Blocker/Diuretic Combination Therapy in Obese, Hypertensive African American and Caucasian Patients

Por Ofili, Elizabeth O., Zappe, Dion H., Purkayastha, Das, Samuel, Rita, Sowers, James R.
Publicado em 2013

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly...

Por Williams, Bryan, Cockcroft, John R, Kario, Kazuomi, Zappe, Dion H, Cardenas, Pamela, Hester, Allen, Brunel, Patrick, Zhang, Jack
Publicado em 2014

Angiotensin Receptor Blocker/Diurectic Combination Preserves Insulin Responses in Obese Hypertensives

Por Sowers, James R., Raij, Leopoldo, Jialal, Ishwaral, Egan, Brent M., Ofili, Elizabeth O., Samuel, Rita, Zappe, Dion H., Purkayastha, Das, Deedwania, Prakash C.
Publicado em 2010

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

Por Brook, Robert D., Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertram, Velazquez, Eric, Weber, Michael, Zappe, Dion H., Hau, Tsushung, Jamerson, Kenneth A.
Publicado no J Am Heart Assoc (2018)